WILHELMUS CM GROENHUYSEN Insider Trading $NVCR NovoCure Ltd
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILHELMUS CM GROENHUYSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILHELMUS CM GROENHUYSEN. WILHELMUS CM GROENHUYSEN is Director in NAVTEQ CORP ($NVT) and Director in OptiNose, Inc. ($OPTN) and CFO in NovoCure Ltd ($NVCR) and Chief Financial Officer in Novocure Ltd ($NVCR) and Chief Operating Officer in NovoCure Ltd ($NVCR).
WILHELMUS CM GROENHUYSEN in NovoCure Ltd
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of WILHELMUS CM GROENHUYSEN: Chief Operating Officer, CFO, Chief Financial Officer
Holdings: 150,014 shares
Current Value: $1,020,095
Latest Transaction: Apr 08 2021
$NVCR Market Capitalization: $581.43M
$NVCR Previous Close: $6.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of WILHELMUS CM GROENHUYSEN in NovoCure Ltd
Sentiment: All, NVT, NVCR, OPTN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.56 | 1,661 | 133,804 | 87,479 | 89.1 K to 87.5 K (-1.86 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 7.03 | 1,961 | 13,786 | 89,140 | 87.2 K to 89.1 K (+2.25 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 7.03 | 1,961 | 13,786 | 89,140 | 87.2 K to 89.1 K (+2.25 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.18 | 700 | 56,824 | 87,179 | 87.9 K to 87.2 K (-0.80 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.18 | 700 | 56,824 | 87,179 | 87.9 K to 87.2 K (-0.80 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.50 | 3,331 | 268,155 | 87,879 | 91.2 K to 87.9 K (-3.65 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.50 | 3,331 | 268,155 | 87,879 | 91.2 K to 87.9 K (-3.65 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 3.44 | 4,031 | 13,867 | 91,210 | 87.2 K to 91.2 K (+4.62 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 3.44 | 4,031 | 13,867 | 91,210 | 87.2 K to 91.2 K (+4.62 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.19 | 300 | 24,358 | 87,179 | 87.5 K to 87.2 K (-0.34 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.19 | 300 | 24,358 | 87,179 | 87.5 K to 87.2 K (-0.34 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.53 | 1,700 | 136,899 | 87,479 | 89.2 K to 87.5 K (-1.91 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.53 | 1,700 | 136,899 | 87,479 | 89.2 K to 87.5 K (-1.91 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 3.44 | 2,000 | 6,880 | 89,179 | 87.2 K to 89.2 K (+2.29 %) |
| Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Buy | M | 3.44 | 2,000 | 6,880 | 89,179 | 87.2 K to 89.2 K (+2.29 %) |
| Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 94,663 | |
| Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 119,663 | |
| Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 79.01 | 22,300 | 1,761,856 | 87,179 | 109.5 K to 87.2 K (-20.37 %) |
| Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 78.33 | 2,700 | 211,478 | 109,479 | 112.2 K to 109.5 K (-2.41 %) |
| Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
| Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.96 | 400 | 32,384 | 87,179 | 87.6 K to 87.2 K (-0.46 %) |
| Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.27 | 13,502 | 1,083,792 | 87,579 | 101.1 K to 87.6 K (-13.36 %) |
| Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 79.24 | 11,098 | 879,372 | 101,081 | 112.2 K to 101.1 K (-9.89 %) |
| Sep 17 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 144,663 | |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 169,663 | |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.05 | 201 | 16,291 | 87,179 | 87.4 K to 87.2 K (-0.23 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.51 | 10,107 | 813,694 | 87,380 | 97.5 K to 87.4 K (-10.37 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 79.42 | 6,499 | 516,151 | 97,487 | 104 K to 97.5 K (-6.25 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 78.50 | 8,193 | 643,142 | 103,986 | 112.2 K to 104 K (-7.30 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 79.19 | 4,061 | 321,599 | 87,179 | 91.2 K to 87.2 K (-4.45 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 78.72 | 11,015 | 867,057 | 91,240 | 102.3 K to 91.2 K (-10.77 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 77.52 | 4,008 | 310,692 | 102,255 | 106.3 K to 102.3 K (-3.77 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 76.37 | 3,974 | 303,478 | 106,263 | 110.2 K to 106.3 K (-3.60 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 75.56 | 1,942 | 146,738 | 110,237 | 112.2 K to 110.2 K (-1.73 %) |
| Sep 13 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 194,663 | |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 25,000 | 86,000 | 219,663 | |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 76.45 | 5,709 | 436,447 | 87,179 | 92.9 K to 87.2 K (-6.15 %) |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 75.28 | 19,291 | 1,452,188 | 92,888 | 112.2 K to 92.9 K (-17.20 %) |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 84.41 | 200 | 16,882 | 87,179 | 87.4 K to 87.2 K (-0.23 %) |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.74 | 1,100 | 91,011 | 87,379 | 88.5 K to 87.4 K (-1.24 %) |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.05 | 10,800 | 886,129 | 88,479 | 99.3 K to 88.5 K (-10.88 %) |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.92 | 4,400 | 356,061 | 99,279 | 103.7 K to 99.3 K (-4.24 %) |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 79.73 | 1,643 | 130,990 | 103,679 | 105.3 K to 103.7 K (-1.56 %) |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 78.70 | 6,857 | 539,673 | 105,322 | 112.2 K to 105.3 K (-6.11 %) |
| Sep 11 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 25,000 | 86,000 | 112,179 | 87.2 K to 112.2 K (+28.68 %) |
| Jul 09 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 27.81 | 454 | 12,627 | 87,179 | 86.7 K to 87.2 K (+0.52 %) |
| May 10 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 47.56 | 20,000 | 951,200 | 20,000 | |
| May 10 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 47.56 | 36,650 | 1,743,074 | 36,650 | |
| Mar 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 47.04 | 37,461 | 1,762,165 | 37,461 | |
| Mar 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 0.00 | 20,461 | 0 | 86,725 | 66.3 K to 86.7 K (+30.88 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 31,234 | 107,445 | 244,663 | |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 40,000 | 137,600 | 275,897 | |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 18,766 | 64,555 | 315,897 | |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 53.40 | 31,234 | 1,668,021 | 66,264 | 97.5 K to 66.3 K (-32.04 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 31,234 | 107,445 | 97,498 | 66.3 K to 97.5 K (+47.14 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 56.50 | 4,342 | 245,336 | 66,264 | 70.6 K to 66.3 K (-6.15 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 55.95 | 2,800 | 156,654 | 70,606 | 73.4 K to 70.6 K (-3.81 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 54.54 | 2,800 | 152,720 | 73,406 | 76.2 K to 73.4 K (-3.67 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 53.82 | 4,207 | 226,404 | 76,206 | 80.4 K to 76.2 K (-5.23 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 52.90 | 25,851 | 1,367,595 | 80,413 | 106.3 K to 80.4 K (-24.33 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 40,000 | 137,600 | 106,264 | 66.3 K to 106.3 K (+60.36 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 56.52 | 5,222 | 295,153 | 66,264 | 71.5 K to 66.3 K (-7.30 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 56.04 | 4,748 | 266,054 | 71,486 | 76.2 K to 71.5 K (-6.23 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 54.56 | 3,400 | 185,497 | 76,234 | 79.6 K to 76.2 K (-4.27 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 53.91 | 5,396 | 290,877 | 79,634 | 85 K to 79.6 K (-6.35 %) |
| Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 18,766 | 64,555 | 85,030 | 66.3 K to 85 K (+28.32 %) |
| Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,717 | 0 | 15,431 | |
| Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,717 | 0 | 15,431 | |
| Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 53.68 | 3,288 | 176,500 | 66,264 | 69.6 K to 66.3 K (-4.73 %) |
| Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 53.68 | 3,288 | 176,500 | 66,264 | 69.6 K to 66.3 K (-4.73 %) |
| Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 52.90 | 7,717 | 408,229 | 69,552 | 61.8 K to 69.6 K (+12.48 %) |
| Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 52.90 | 7,717 | 408,229 | 69,552 | 61.8 K to 69.6 K (+12.48 %) |
| Jan 28 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 35,000 | 120,400 | 334,663 | |
| Jan 28 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 49.20 | 35,000 | 1,722,000 | 37,149 | 72.1 K to 37.1 K (-48.51 %) |
| Jan 28 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 35,000 | 120,400 | 72,149 | 37.1 K to 72.1 K (+94.22 %) |
| Jan 25 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 35,000 | 120,400 | 369,663 | |
| Jan 25 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 47.35 | 35,000 | 1,657,250 | 37,149 | 72.1 K to 37.1 K (-48.51 %) |
| Jan 25 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 35,000 | 120,400 | 72,149 | 37.1 K to 72.1 K (+94.22 %) |
| Jan 22 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 30,000 | 103,200 | 404,663 | |
| Jan 22 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 45.90 | 30,000 | 1,376,910 | 37,149 | 67.1 K to 37.1 K (-44.68 %) |
| Jan 22 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 30,000 | 103,200 | 67,149 | 37.1 K to 67.1 K (+80.76 %) |
| Jan 16 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 30,000 | 103,200 | 434,663 | |
| Jan 16 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 44.20 | 30,000 | 1,326,000 | 37,149 | 67.1 K to 37.1 K (-44.68 %) |
| Jan 16 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 30,000 | 103,200 | 67,149 | 37.1 K to 67.1 K (+80.76 %) |
| Jan 14 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 30,000 | 103,200 | 464,663 | |
| Jan 14 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 42.35 | 30,000 | 1,270,500 | 37,149 | 67.1 K to 37.1 K (-44.68 %) |
| Jan 14 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 30,000 | 103,200 | 67,149 | 37.1 K to 67.1 K (+80.76 %) |
| Jan 14 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 27.20 | 25 | 680 | 37,149 | 37.1 K to 37.1 K (+0.07 %) |
| Aug 28 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 40.03 | 9,973 | 399,203 | 37,124 | 47.1 K to 37.1 K (-21.18 %) |
| Aug 28 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 40.05 | 100 | 4,005 | 47,097 | 47.2 K to 47.1 K (-0.21 %) |
| Aug 28 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 40.03 | 200 | 8,005 | 47,197 | 47.4 K to 47.2 K (-0.42 %) |
| Aug 28 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 40.00 | 25,274 | 1,010,960 | 47,397 | 72.7 K to 47.4 K (-34.78 %) |
| Aug 24 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.67 | 31,179 | 1,174,603 | 72,671 | 103.9 K to 72.7 K (-30.02 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.50 | 2,300 | 86,250 | 103,850 | 106.2 K to 103.9 K (-2.17 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.60 | 100 | 3,760 | 106,150 | 106.3 K to 106.2 K (-0.09 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.65 | 300 | 11,295 | 106,250 | 106.6 K to 106.3 K (-0.28 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.55 | 200 | 7,510 | 106,550 | 106.8 K to 106.6 K (-0.19 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.75 | 500 | 18,875 | 106,750 | 107.3 K to 106.8 K (-0.47 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.70 | 200 | 7,540 | 107,250 | 107.5 K to 107.3 K (-0.19 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.80 | 68 | 2,570 | 107,450 | 107.5 K to 107.5 K (-0.06 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 38.00 | 200 | 7,600 | 107,518 | 107.7 K to 107.5 K (-0.19 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.90 | 400 | 15,160 | 107,718 | 108.1 K to 107.7 K (-0.37 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.85 | 100 | 3,785 | 108,118 | 108.2 K to 108.1 K (-0.09 %) |
| Aug 06 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.05 | 1,790 | 62,740 | 108,218 | 110 K to 108.2 K (-1.63 %) |
| Aug 06 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.00 | 5,336 | 186,760 | 110,008 | 115.3 K to 110 K (-4.63 %) |
| Aug 02 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.05 | 100 | 3,505 | 115,344 | 115.4 K to 115.3 K (-0.09 %) |
| Aug 02 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.03 | 200 | 7,005 | 115,444 | 115.6 K to 115.4 K (-0.17 %) |
| Aug 02 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.00 | 941 | 32,935 | 115,644 | 116.6 K to 115.6 K (-0.81 %) |
| Jul 30 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.05 | 1,100 | 40,755 | 116,585 | 117.7 K to 116.6 K (-0.93 %) |
| Jul 30 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 36.60 | 6,095 | 223,077 | 117,685 | 123.8 K to 117.7 K (-4.92 %) |
| Jul 30 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.20 | 34,385 | 1,210,352 | 123,780 | 158.2 K to 123.8 K (-21.74 %) |
| Jul 30 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 34.44 | 17,437 | 600,530 | 158,165 | 175.6 K to 158.2 K (-9.93 %) |
| Jul 30 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 33.86 | 3,710 | 125,621 | 175,602 | 179.3 K to 175.6 K (-2.07 %) |
| Jul 10 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 17.26 | 1,191 | 20,551 | 179,312 | 178.1 K to 179.3 K (+0.67 %) |
| Feb 26 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 0.00 | 43,334 | 0 | 86,666 | |
| Feb 26 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 19.83 | 13,351 | 264,724 | 239,061 | 252.4 K to 239.1 K (-5.29 %) |
| Feb 26 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 21.55 | 43,334 | 933,848 | 252,412 | 209.1 K to 252.4 K (+20.73 %) |
| Jan 10 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 21.02 | 31,132 | 654,376 | 209,078 | 240.2 K to 209.1 K (-12.96 %) |
| Jan 10 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 15.05 | 310 | 4,664 | 240,210 | 239.9 K to 240.2 K (+0.13 %) |
| Jan 05 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 21.03 | 26,264 | 552,314 | 239,900 | 266.2 K to 239.9 K (-9.87 %) |
| Jan 05 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 21.00 | 2,404 | 50,484 | 266,164 | 268.6 K to 266.2 K (-0.90 %) |
| Jan 05 2018 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 21.03 | 200 | 4,205 | 268,568 | 268.8 K to 268.6 K (-0.07 %) |
| Jul 07 2017 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 6.67 | 2,484 | 16,576 | 268,768 | 266.3 K to 268.8 K (+0.93 %) |
| Feb 24 2017 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 0.00 | 130,000 | 0 | 130,000 | |
| Feb 24 2017 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 7.15 | 292,500 | 2,091,375 | 292,500 | |
| Jan 06 2017 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 6.67 | 3,156 | 21,060 | 266,284 | 263.1 K to 266.3 K (+1.20 %) |
| Jan 14 2016 | NVCR | Novocure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 21.90 | 450,000 | 9,855,000 | 450,000 |